Soleno Therapeutics Inc Working Capital to Net Assets Ratio
Soleno Therapeutics Inc working capital to net assets ratio. Soleno Therapeutics Inc (SLNO) has a Working Capital to Net Assets ratio of 54.1% as of March 2026. Working capital of $268.33 Million (current assets of $326.38 Million minus current liabilities of $58.05 Million) is measured against net assets of $495.80 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Soleno Therapeutics Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Soleno Therapeutics Inc (2012–2025)
Working capital to net assets ratio of Soleno Therapeutics Inc from 2012 to 2025. This chart shows how Soleno Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 54.1%, reflecting working capital of $268.33 Million against net assets of $495.80 Million USD. See how many days can Soleno Therapeutics Inc fund operations to measure how many days the company can operate on defensive assets alone.
Soleno Therapeutics Inc Working Capital to Net Assets Ratio by Year (2012–2025)
Soleno Therapeutics Inc working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Soleno Therapeutics Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see SLNO total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 65.4% | $294.45 Million | $450.12 Million | $355.81 Million | $61.36 Million | ▼ -46.8 pp |
| 2024 | 112.3% | $275.14 Million | $245.11 Million | $293.89 Million | $18.75 Million | ▲ +10.8 pp |
| 2023 | 101.5% | $159.85 Million | $157.51 Million | $171.36 Million | $11.51 Million | ▲ +21.0 pp |
| 2022 | 80.5% | $8.33 Million | $10.35 Million | $15.65 Million | $7.31 Million | ▼ -0.5 pp |
| 2021 | 81.0% | $14.41 Million | $17.79 Million | $22.42 Million | $8.01 Million | ▼ -10.4 pp |
| 2020 | 91.4% | $41.62 Million | $45.55 Million | $50.24 Million | $8.62 Million | ▼ -16.9 pp |
| 2019 | 108.2% | $16.18 Million | $14.95 Million | $21.14 Million | $4.96 Million | ▲ +33.3 pp |
| 2018 | 74.9% | $22.79 Million | $30.41 Million | $24.67 Million | $1.88 Million | ▲ +13.7 pp |
| 2017 | 61.3% | $16.26 Million | $26.53 Million | $17.99 Million | $1.73 Million | ▲ +0.3 pp |
| 2016 | 61.0% | $2.09 Million | $3.44 Million | $3.80 Million | $1.71 Million | ▼ -38.7 pp |
| 2015 | 99.6% | $3.21 Million | $3.22 Million | $6.40 Million | $3.19 Million | ▲ +167.8 pp |
| 2014 | -68.2% | $7.05 Million | $-10.33 Million | $8.34 Million | $1.29 Million | ▼ -101.6 pp |
| 2013 | 33.4% | $-12.65 Million | $-37.86 Million | $1.52 Million | $14.18 Million | ▲ +6.6 pp |
| 2012 | 26.8% | $-9.15 Million | $-34.20 Million | $2.39 Million | $11.54 Million | — |